Nkarta (NKTX)

Technical Analysis Historical Data Financials News & Analysis

NKTX NEWS

Nkarta, Inc. (NASDAQ:NKTX) Stocks Received via Financial institution of The united states Corp DE By MarketBeat - 2 weeks ago

Bank of America Corp DE lifted its position in shares of Nkarta, Inc. (NASDAQ:NKTX – Free Report) by 110.1% during the fourth quarter, Holdings Channel reports. The firm owned 380,444 shares of the c… [+3742 chars]...

Read more
Nkarta Appoints Shawn Rose Leader Scientific Officer & Head of R&D as Corporation Resets Senior Management Function for Autoimmune Focal point By Site Author - 2 weeks ago

SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to trea… [+7063 chars]...

Read more
Mizuho Lowers Nkarta (NASDAQ:NKTX) Worth Goal to $14.00 By MarketBeat - 2 weeks ago

Nkarta (NASDAQ:NKTX – Free Report) had its price target decreased by Mizuho from $16.00 to $14.00 in a research report report published on Tuesday,Benzinga reports. Mizuho currently has an outperform… [+3821 chars]...

Read more
Nkarta, Inc. (NASDAQ:NKTX) Receives $14.67 Moderate PT from Brokerages By MarketBeat - 1 week ago

Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) has been assigned a consensus rating of “Buy” from the eight analysts that are currently covering the company, MarketBeat reports. One analyst has rated t… [+3282 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		198.9 -2.04
-1.02%
CVX 		143.23 -0.32
-0.22%
CAT 		371.58 -1.44
-0.39%
INTC 		22.2 -0.35
-1.55%
MSFT 		492.27 2.16
0.44%
DIS 		119.42 0.77
0.65%
DOW 		26.82 -0.71
-2.58%
CSCO 		68.19 0.3
0.44%
GS 		669.87 7.76
1.17%